Business · 16/12/2009
FDA Amends Animal Drug Regulations for Ketamine Hydrochloride
The FDA is updating its rules to reflect a change in sponsorship for an abbreviated new animal drug application for ketamine hydrochloride injectable solution, switching from Bioniche Animal Health USA, Inc. to Bioniche Teoranta.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →